BAIT
NR3C1
GCCR, GCR, GCRST, GR, GRL
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
GO Process (8)
GO Function (8)
GO Component (4)
Gene Ontology Biological Process
- cellular response to steroid hormone stimulus [IDA]
- gene expression [TAS]
- positive regulation of transcription from RNA polymerase II promoter [IDA]
- regulation of transcription, DNA-templated [IDA]
- signal transduction [TAS]
- transcription from RNA polymerase II promoter [TAS]
- transcription initiation from RNA polymerase II promoter [TAS]
- transcription, DNA-templated [TAS]
Gene Ontology Molecular Function- RNA polymerase II core promoter proximal region sequence-specific DNA binding [IDA]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [IDA]
- glucocorticoid receptor activity [TAS]
- glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity [IDA]
- protein binding [IPI]
- sequence-specific DNA binding transcription factor activity [IDA]
- steroid binding [IDA]
- steroid hormone binding [IDA]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding [IDA]
- RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [IDA]
- glucocorticoid receptor activity [TAS]
- glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity [IDA]
- protein binding [IPI]
- sequence-specific DNA binding transcription factor activity [IDA]
- steroid binding [IDA]
- steroid hormone binding [IDA]
Gene Ontology Cellular Component
Homo sapiens
PREY
PPARG
CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma
peroxisome proliferator-activated receptor gamma
GO Process (39)
GO Function (14)
GO Component (4)
Gene Ontology Biological Process
- G-protein coupled receptor signaling pathway [TAS]
- activation of cysteine-type endopeptidase activity involved in apoptotic process [IDA]
- cell fate commitment [ISS]
- cell maturation [IDA]
- cellular response to insulin stimulus [IMP]
- epithelial cell differentiation [ISS]
- gene expression [TAS]
- glucose homeostasis [IMP]
- innate immune response [TAS]
- lipid homeostasis [TAS]
- lipid metabolic process [TAS]
- lipoprotein transport [IDA]
- long-chain fatty acid transport [ISS]
- low-density lipoprotein particle receptor biosynthetic process [IDA]
- monocyte differentiation [IDA]
- negative regulation of cholesterol storage [IDA]
- negative regulation of interferon-gamma-mediated signaling pathway [IMP]
- negative regulation of macrophage derived foam cell differentiation [IC, IDA]
- negative regulation of receptor biosynthetic process [IDA]
- negative regulation of sequestering of triglyceride [IDA]
- negative regulation of smooth muscle cell proliferation [IDA]
- negative regulation of transcription from RNA polymerase II promoter [IDA, ISS]
- negative regulation of transcription, DNA-templated [ISS]
- peroxisome proliferator activated receptor signaling pathway [IMP]
- placenta development [ISS]
- positive regulation of fat cell differentiation [ISS]
- positive regulation of sequence-specific DNA binding transcription factor activity [IDA]
- positive regulation of transcription from RNA polymerase II promoter [IDA, IMP]
- positive regulation of transcription, DNA-templated [ISS]
- regulation of blood pressure [IMP]
- regulation of cholesterol transporter activity [IC]
- regulation of transcription involved in cell fate commitment [ISS]
- response to lipid [ISS]
- response to low-density lipoprotein particle [IDA]
- response to nutrient [TAS]
- response to retinoic acid [IDA]
- signal transduction [IDA]
- transcription initiation from RNA polymerase II promoter [TAS]
- white fat cell differentiation [ISS, TAS]
Gene Ontology Molecular Function- DNA binding [IDA, ISS]
- activating transcription factor binding [IDA]
- arachidonic acid binding [ISS]
- chromatin binding [ISS]
- drug binding [IDA]
- enzyme binding [IPI]
- ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [IDA]
- ligand-dependent nuclear receptor transcription coactivator activity [IDA]
- prostaglandin receptor activity [TAS]
- protein binding [IPI]
- retinoid X receptor binding [IDA]
- sequence-specific DNA binding [IDA]
- sequence-specific DNA binding transcription factor activity [IDA, ISS]
- transcription regulatory region DNA binding [IDA, ISS]
- DNA binding [IDA, ISS]
- activating transcription factor binding [IDA]
- arachidonic acid binding [ISS]
- chromatin binding [ISS]
- drug binding [IDA]
- enzyme binding [IPI]
- ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [IDA]
- ligand-dependent nuclear receptor transcription coactivator activity [IDA]
- prostaglandin receptor activity [TAS]
- protein binding [IPI]
- retinoid X receptor binding [IDA]
- sequence-specific DNA binding [IDA]
- sequence-specific DNA binding transcription factor activity [IDA, ISS]
- transcription regulatory region DNA binding [IDA, ISS]
Gene Ontology Cellular Component
Homo sapiens
Affinity Capture-Western
An interaction is inferred when a bait protein is affinity captured from cell extracts by either polyclonal antibody or epitope tag and the associated interaction partner identified by Western blot with a specific polyclonal antibody or second epitope tag. This category is also used if an interacting protein is visualized directly by dye stain or radioactivity. Note that this differs from any co-purification experiment involving affinity capture in that the co-purification experiment involves at least one extra purification step to get rid of potential contaminating proteins.
Publication
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Chemokine-mediated inflammatory cell infiltration is a hallmark of asthma. We recently demonstrated that glucocorticoids and beta(2)-agonists additively or synergistically suppress tumor necrosis factor-alpha (TNFalpha)-induced production of chemokines eotaxin and interleukin-8 (IL-8), respectively, in human airway smooth muscle (HASM) cells, which may partly explain their combined benefits in asthma. Peroxisome proliferator-activated receptors (PPARs) also modulate inflammatory gene expression. We reported here ... [more]
J. Biol. Chem. Jan. 28, 2005; 280(4);2550-61 [Pubmed: 15531761]
Throughput
- Low Throughput
Ontology Terms
- tissue: trachea (BTO:0001388) [trachea (UBERON:0003126)|tracheal smooth muscle cell (BTO:0004403)]
Additional Notes
- Interaction increased when cells also pre-treated with fluticasone or salmeterol
- Interaction occurred when SMCs were treated with 15d-PGJ2 (PPARG natural agonist) and then TNF-alpha
Curated By
- BioGRID